Has Eric Brass received payments from drug or device companies?

Yes. Drug and device makers reported $754,833 in general payments to Eric Brass across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Brass did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Brass come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Brass

General Practice · Torrance, CANPI 1215908512

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $635,413 of the $754,833 with a category attached, or 84.2%. 11 manufacturers reported payments, led by Novo Nordisk at 52.8% of the total. Reporting peaked in 2019 at $205,458 and has fallen 66.5% since, to $68,856 in 2025. Among general practice clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$754,833in general payments, 2019–2025

Across 223 payments — averaging $3384.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$399K
HRA Pharma$170K
Leadiant Biosciences, Inc.$93K
Novo Nordisk AS$37K
Bayer Healthcare LLC$19K
Intercept Pharmaceuticals, Inc.$9K
plus $29K from 5 others

$10,193in research payments, 2019–2025

Across 6 payments — averaging $1698.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Chiesi USA, Inc.$10K

What the payments were for

Consulting fees$635,41384%
Travel & lodging$113,49115%
Food & beverage$5,9291%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	112	$398,759
HRA Pharma	16	$169,702
Leadiant Biosciences, Inc.	55	$92,863
Novo Nordisk AS	13	$36,921
Bayer Healthcare LLC	10	$18,975
Intercept Pharmaceuticals, Inc.	3	$8,681
Amgen	8	$7,758
Sanofi US Services Inc.	2	$6,600
Takeda Pharmaceuticals U.S.A., Inc.	1	$6,050
Incyte Corporation	1	$5,775
Bayer	2	$2,750

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Norditropin$40,009
Ella$37,725
FIASP$18,978
NovoSeven$12,238
EVENITY$7,563
Sogroya$7,150
CDCA$6,050
Tresiba$5,225
REBINYN$4,675
ManNAc$1,925

How this compares

$754,833 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.

See all general practice providers in California →

Other general practice in Torrance

Darrell HarringtonTorrance$116K
Nathan LiLancaster$5.2M
Milton McCollSan Jose$4.9M
Frederic MollRedwood City$2.5M
Bradley ChingUpland$1.4M
Marc GeissbergerGreenbrae$583K
Robert CampbellLong Beach$501K
Varo BoyerNorth Hills$482K
Michael MiyasakiSacramento$464K
Apolinar MadrigalCeres$419K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →